The next generation of DCTs: inside the technology transforming clinical trials
Within the last decade, the way clinical trials are done has been revolutionised by technology. Pharmaceutical companies are embracing the…
In association with Novotech
Accelerating Clinical Trials
Latest in
Accelerating Clinical Trials
A booming market: Why the Chinese biotech sector is primed for growth
Established itself as the second largest market in the world, behind only the United States, the Chinese pharmaceutical sector is…
Clinical trial trends in 2022: Prepare for an agile future
As we enter 2022, the third year of the Covid-19 pandemic, the clinical research landscape is undergoing a transformation –…
Why Asia-Pacific is the next frontier for decentralised clinical trials
Decentralised Clinical Trials (DCTs) are trials that use digital technologies to communicate with study participants, bring clinical research closer to patient’s…
Four key strategies for Western biotechs to expedite drug development in China
Home to a booming clinical trials market, China presents a huge opportunity for clinical innovation. Since 2015, the country has…
Home to around 20% of the world’s population, research regulatory reform creates tremendous opportunity for Western biotechs in China
Alongside a large patient population, China offers a large and growing network of hospitals qualified to conduct high-standard clinical trials…
How a drug development plan can save your biotech money
The drug development industry has seen a major shift of clinical activity away from large pharmaceutical companies in favour of…
The benefit of running clinical trials in Asia-Pacific for biotech companies
According to Frost & Sullivan, the CRO market is forecast to grow to US$ 71.7billion by 2024 (+8% CAGR 19-24F).…
Is Australia the future for successful first-in-human clinical studies?
The number of biotech-sponsored clinical trials in Australia has grown by more than +10% on average each year between 2017…
How biotechs can tap APAC for excellence in oncology trials
Asia-Pacific biotech specialist CRO Novotech has released a new webinar about the advantages of conducting oncology clinical trials in the…
Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of…
Clinical Trial Continuity in Asia-Pacific during the COVID-19 pandemic
The leading Asia-Pacific biotech specialist CRO Novotech is releasing a series of webinars about the advantages of conducting clinical trials…
Biotechs testing for COVID-19 in Asia-Pacific benefit from new fast-track review processes
Many countries in the Asia-Pacific region are now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment…
Data shows majority of Australian sites are open for clinical trial activity
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the…
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments…
Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial
The alliance of regional specialists can provide the best of all worlds: global coverage, regional specialisation and mid-sized CRO flexibility.…
Case studies in accelerating clinical trials in oncology
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years. As of December 2019, over 6,000…
Regulatory requirements for clinical trials: A comparison of Australia and the US
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international biotech companies wanting a fast…